InvaGen Pharmaceuticals Inc.
- Targets
- 1
- Filings
- 2
- Median premium
- 235%
- First filing
- Dec 11, 2018
- Latest filing
- Dec 21, 2018
Targets
| Company | Score before deal | Score now | Filings | Latest |
|---|---|---|---|---|
| ATXIAVENUE THERAPEUTICS, INC. | — | 0 / 13 | 2 | Dec 21, 2018 |
| Company | Score before deal | Score now | Filings | Latest |
|---|---|---|---|---|
| ATXIAVENUE THERAPEUTICS, INC. | — | 0 / 13 | 2 | Dec 21, 2018 |